Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

Gastroenterology. 2018 Feb;154(3):752-754.e1. doi: 10.1053/j.gastro.2017.08.067. Epub 2017 Oct 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / metabolism*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Breast Feeding* / adverse effects
  • Case-Control Studies
  • Female
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / metabolism*
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases / diagnosis
  • Inflammatory Bowel Diseases / drug therapy*
  • Lactation / metabolism*
  • Milk, Human / metabolism*
  • Risk Assessment
  • Time Factors
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab